The EFFECT OF AN INFUSION OF HIBISCUS SABDARIFFA L. IN HYPERTENSIVE PATIENTS FROM AN URBAN POPULATION: AN IMPORTANT COMORBIDITY BEFORE COVID-19.

Effect of an infusion of Hibiscus sabdariffa L. in hypertensive patients

Authors

  • Rubio Perla Yuridia MONTES Research professor in ICSa-UAEH
  • Illescas Héctor Enrique FABELA Departamento de Cardiometabólicas y Envejecimiento, Jurisdicción Sanitaria 2 Tulancigo de Bravo Servicios de Salud IMSS-Bienestar, Hidalgo, Mexico.
  • Munive Alvaro Guillermo ISLAS- Departamento de Cardiometabólicas y Envejecimiento, Jurisdicción Sanitaria 2 Tulancigo de Bravo Servicios de Salud IMSS-Bienestar, Hidalgo, Mexico.
  • -Vázquez Josefina REYNOSO Departamento de Farmacia y Maestría en Salud Púbica. Universidad Autónoma del Estado de Hidalgo, Hidalgo, Mexico.
  • -Guerrero Beatriz GARNICA Estudiante de Licenciatura en Nutrición en Universidad Autónoma de Durango, México.
  • Ledezma Jesús Carlos RUVALCABA- Departamento de Medicina y Maestría en Salud Pública. Universidad Autónoma del Estado de Hidalgo, Hidalgo, Mexico.

DOI:

https://doi.org/10.21010/AJTCAM%20v20i1.1

Keywords:

hypertension, roselle, Hibiscus sabdariffa L, infusion, blood pressure

Abstract

Background: Roselle (Hibiscus sabdariffa L.) has traditionally been used in folk medicine to treat hypertension; however, clinical studies are limited to show efficacy as an antihypertensive. Today, hypertension is an important comorbidity in the face of the covid-19 pandemic. The objective of this study was to assess the effect of a commercial H. sabdariffa infusion on blood pressure (BP) levels in hypertensive patients through a pilot clinical study.

Materials and Methods: Patients with a previous diagnosis of hypertension were chosen, regardless of their BP figures, who frequently came for consultations at a health center. The infusion (10 g/240 mL) was administered orally daily for four weeks in 33 patients, 11 of them presented uncontrolled levels of BP.

Results: Statistically significant differences were found in diastolic blood pressure (DBP) values, but not for systolic blood pressure (SBP) (n=33), suggesting that the values could decrease until being significant with a longer supplementation time or higher doses. In uncontrolled patients (n=11), both SBP and DBP showed a significant decrease.

Conclusion: The results showed that the use of H. sabdariffa in this study could be useful in the management of patients with hypertension. However, future studies should be performed on larger samples so that effectiveness can be fully determined.

Author Biography

Rubio Perla Yuridia MONTES, Research professor in ICSa-UAEH

Medicine

Downloads

Published

2024-12-20

How to Cite

MONTES, R. P. Y., FABELA, I. H. E., ISLAS-, M. A. G., REYNOSO, .-V. J., GARNICA, .-G. B., & RUVALCABA-, L. J. C. (2024). The EFFECT OF AN INFUSION OF HIBISCUS SABDARIFFA L. IN HYPERTENSIVE PATIENTS FROM AN URBAN POPULATION: AN IMPORTANT COMORBIDITY BEFORE COVID-19.: Effect of an infusion of Hibiscus sabdariffa L. in hypertensive patients. African Journal of Traditional, Complementary and Alternative Medicines, 20(1), 1–7. https://doi.org/10.21010/AJTCAM v20i1.1

Issue

Vol. 20 No. 1 (2023)

Section

Research Papers

License

Copyright (c) 2024 Rubio Perla Yuridia MONTES, Illescas Héctor Enrique FABELA, Munive Alvaro Guillermo ISLAS-, -Vázquez Josefina REYNOSO, -Guerrero Beatriz GARNICA, Ledezma Jesús Carlos RUVALCABA-

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright: Creative Commons Attribution CC.

This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. View License Deed | View Legal Code Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.